PulseAugur
EN
LIVE 01:47:43
ENTITY Stock Connect

Stock Connect

PulseAugur coverage of Stock Connect — every cluster mentioning Stock Connect across labs, papers, and developer communities, ranked by signal.

Show in brief
Total · 30d
4
5 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
0
0 over 90d
TIER MIX · 90D
TOPICS
RECENT · PAGE 1/1 · 6 TOTAL
  1. RESEARCH · CL_246428 ·

    China details strategy to boost global renminbi use and mainland listings

    China is implementing a strategy to increase the global use of its currency, the renminbi, which it deems an irreversible trend. This plan involves expanding the digital yuan's use, optimizing market access schemes like…

  2. RESEARCH · CL_212719 ·

    Ping An eyes Hong Kong ETFs as China eases cross-border investment rules

    China's largest insurer, Ping An, is considering investing in Hong Kong-listed exchange-traded funds (ETFs) following regulatory approval from Beijing. This move, supported by the National Financial Regulatory Administr…

  3. RESEARCH · CL_182682 ·

    China raises $2.2B in Hong Kong bonds amid global investor interest

    China's Ministry of Finance is planning to raise 15 billion yuan (approximately US$2.22 billion) through a sovereign bond auction in Hong Kong. This move follows the recent launch of China government bond futures in Hon…

  4. RESEARCH · CL_160446 ·

    Stock Connect adds Hesai Technology-W, SG Microelectronics; Copper prices surge

    The Shenzhen Stock Exchange has announced adjustments to the Stock Connect program, adding Hesai Technology-W, SG Microelectronics, and Scienaptic Systems to its list of eligible Hong Kong-listed stocks, effective July …

  5. COMMENTARY · CL_144082 ·

    Hong Kong IPO market seeks diversification to regain global title

    A government think tank in Hong Kong has proposed a strategy for the city to regain its status as a leading global IPO venue. The Financial Services Development Council (FSDC) suggests diversifying the sources of both l…

  6. SIGNIFICANT · CL_09018 ·

    Dongyangguk Pharmaceutical's H-share full circulation approved, market cap triples

    Dongying Pharmaceutical's H-share full circulation has been approved by the China Securities Regulatory Commission. This allows 208 million domestic shares, representing 36.05% of the total share capital, to be converte…